Coronavirus tally: Pfizer says updated COVID-19 booster is better against omicron, as cases top 100,000 again

Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.76% and BioNTech SE /zigman2/quotes/214419716/composite BNTX -1.22% said over the weekend that the change they made to their COVID-19 vaccine that targets the omicron variant is both safe and effective. The announcement comes as the U.S. Food and Drug Administration considers this week if it should order a formula change for vaccines in hopes that the modified vaccines could protect against another COVID-19 surge that is expected in the fall and the winter. The seven-day average of new daily COVID-19 cases was 102,818 on Sunday, the third-straight day above the 100,000 mark, and up 14% from two weeks ago, according to a New York Times Tracker . The daily average of hospitalizations rose to 31,591, up 6% form two weeks ago and the most since March 9, while daily deaths increased 5% from two weeks ago to 348.

/zigman2/quotes/202877789/composite

Add to watchlist PFE

Pfizer Inc.

US : U.S.: NYSE

$ 32.40

-0.58 -1.76%

Volume: 26.02M

Sept. 26, 2023 4:02p

P/E Ratio

8.63

Dividend Yield

5.06%

Market Cap

$186.20 billion

Rev. per Employee

$939,084

/zigman2/quotes/214419716/composite

Add to watchlist BNTX

BioNTech SE ADR

US : U.S.: Nasdaq

$ 101.86

-1.26 -1.22%

Volume: 419,165

Sept. 26, 2023 4:00p

P/E Ratio

5.72

Dividend Yield

0.00%

Market Cap

$24.73 billion

Rev. per Employee

$2.08M